Cargando…
Hyaluronic Acid-Based Injective Medical Devices: In Vitro Characterization of Novel Formulations Containing Biofermentative Unsulfated Chondroitin or Extractive Sulfated One with Cyclodextrins
Currently, chondroitin sulfate (CS) and hyaluronic acid (HA) pharma-grade forms are used for osteoarthritis (OA) management, CS as an oral formulations component, and HA as intra-articular injective medical devices. Recently, unsulfated chondroitin, obtained through biofermentative (BC) manufacturin...
Autores principales: | Vassallo, Valentina, Di Meo, Celeste, Toro, Giuseppe, Alfano, Alberto, Iolascon, Giovanni, Schiraldi, Chiara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610477/ https://www.ncbi.nlm.nih.gov/pubmed/37895900 http://dx.doi.org/10.3390/ph16101429 |
Ejemplares similares
-
Potential of Biofermentative Unsulfated Chondroitin and Hyaluronic Acid in Dermal Repair
por: D’Agostino, Antonella, et al.
Publicado: (2022) -
Molecular Fingerprint of Human Pathological Synoviocytes in Response to Extractive Sulfated and Biofermentative Unsulfated Chondroitins
por: Vassallo, Valentina, et al.
Publicado: (2022) -
Timely Supplementation of Hydrogels Containing Sulfated or Unsulfated Chondroitin and Hyaluronic Acid Affects Mesenchymal Stromal Cells Commitment Toward Chondrogenic Differentiation
por: Alessio, Nicola, et al.
Publicado: (2021) -
Evaluation of novel biomaterials for cartilage regeneration based on gelatin methacryloyl interpenetrated with extractive chondroitin sulfate or unsulfated biotechnological chondroitin
por: Vassallo, Valentina, et al.
Publicado: (2022) -
Differential Secretome Profiling of Human Osteoarthritic Synoviocytes Treated with Biotechnological Unsulfated and Marine Sulfated Chondroitins
por: Russo, Rosita, et al.
Publicado: (2020)